Proclemer Alessandro, Zecchin Massimo, D'Onofrio Antonio, Boriani Giuseppe, Botto Giovanni Luca, Facchin Domenico, Rebellato Luca, Ghidina Marco, Bianco Giulia, Bernardelli Emanuela, Pucher Elsa, Gregori Dario
S.O.C. Cardiologia e Fondazione IRCAB, Azienda Sanitaria Universitaria Integrata S. Maria della Misericordia, Udine.
Dipartimento Cardiovascolare, Azienda Ospedaliero-Universitaria "Ospedali Riuniti", Trieste.
G Ital Cardiol (Rome). 2017 Jan;18(1):67-79. doi: 10.1714/2628.27024.
The pacemaker (PM) and implantable cardioverter-defibrillator (ICD) Registry of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) monitors the main epidemiological data in real-world practice. The survey for the 2015 activity collects information about demographics, clinical characteristics, main indications for PM/ICD therapy and device types from the Italian collaborating centers.
The Registry collects prospectively national PM and ICD implantation activity on the basis of European cards.
PM Registry: data about 24 285 PM implantations were collected (19 194 first implant and 5091 replacements). The number of collaborating centers was 218. Median age of treated patients was 81 years (75 quartile I; 86 quartile III). ECG indications included atrioventricular conduction disorders in 42.8% of first PM implants, sick sinus syndrome in 22.9%, atrial fibrillation plus bradycardia in 15.1%, other in 19.2%. Among atrioventricular conduction defects, third-degree atrioventricular block was the most common type (23.8% of first implants). Use of single-chamber PMs was reported in 26.9% of first implants, of dual-chamber PMs in 63.4%, of PMs with cardiac resynchronization therapy (CRT) in 1.8%, and of single lead atrial-synchronized ventricular stimulation (VDD/R PMs) in 7.9%. ICD Registry: data about 15 363 ICD implantations were collected (11 453 first implants and 3910 replacements). The number of collaborating centers was 434. Median age of treated patients was 71 years (63 quartile I; 78 quartile III]. Primary prevention indication was reported in 77.3% of first implants, secondary prevention in 22.7% (cardiac arrest in 8.0%). A single-chamber ICD was used in 29.3% of first implants, dual-chamber in 34.6% and biventricular in 36.1%.
The PM and ICD Registry appears fundamental for monitoring PM and ICD utilization on a large national scale with rigorous examination of demographics and clinical indications. The PM Registry showed stable electrocardiographic and symptom indications, with an important prevalence of dual-chamber pacing. The use of CRT-PM regards a very limited number of patients. The ICD Registry documented a large use of prophylactic and biventricular ICD, reflecting a favorable adherence to trials and guidelines in clinical practice.
意大利心律失常与心脏起搏协会(AIAC)的起搏器(PM)和植入式心脏复律除颤器(ICD)注册登记处监测实际临床中的主要流行病学数据。2015年活动调查从意大利各协作中心收集了有关人口统计学、临床特征、PM/ICD治疗的主要适应证及器械类型的信息。
该注册登记处基于欧洲卡片前瞻性收集全国范围内的PM和ICD植入活动数据。
PM注册登记处:收集了24285例PM植入的数据(19194例首次植入和5091例更换)。协作中心数量为218个。接受治疗患者的年龄中位数为81岁(四分位数间距I为75;四分位数间距III为86)。心电图适应证方面,首次PM植入中42.8%为房室传导障碍,22.9%为病态窦房结综合征,15.1%为心房颤动合并心动过缓,19.2%为其他情况。在房室传导缺陷中,三度房室传导阻滞是最常见类型(首次植入的23.8%)。首次植入中26.9%报告使用单腔PM,63.4%使用双腔PM,1.8%使用心脏再同步治疗(CRT)的PM,7.9%使用单导联心房同步心室刺激(VDD/R PM)。ICD注册登记处:收集了15363例ICD植入的数据(11453例首次植入和3910例更换)。协作中心数量为434个。接受治疗患者的年龄中位数为71岁(四分位数间距I为63;四分位数间距III为78)。首次植入中77.3%报告为一级预防适应证,22.7%为二级预防(心脏骤停占8.0%)。首次植入中29.3%使用单腔ICD,34.6%使用双腔ICD,36.1%使用双心室ICD。
PM和ICD注册登记处对于在全国范围内大规模监测PM和ICD的使用情况、严格审查人口统计学和临床适应证显得至关重要。PM注册登记处显示心电图和症状适应证稳定,双腔起搏占重要比例。CRT-PM的使用涉及患者数量非常有限。ICD注册登记处记录了预防性和双心室ICD的大量使用,反映出临床实践中对试验和指南的良好遵循情况。